Meiji Holdings Co stock analysis
Meiji Holdings Co (MEJHF) Stock Price & Analysis
MEJHF Stock Chart & Stats
- Day’s Range
- $20.98 - $24.80
- 52-Week Range
- $17.80 - $28.09
- Previous Close
- $22.89
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $7.95B
- Enterprise Value
- $1.14T
- Total Cash (Recent Filing)
- $82.74B
- Total Debt (Recent Filing)
- $143.94B
- Price to Earnings (P/E)
- 29.8
- Beta
- -0.04
- Next Earnings
- Feb 11, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 3.36%
Bulls Say, Bears Say
Bulls Say
Conservative Leverage
Conservative leverage and a substantially larger equity base provide Meiji with balance-sheet resilience across its food and pharmaceutical businesses. This financial capacity can support continued operations and strategic investment while reducing exposure to debt-related stress over the next several quarters.
Revenue Expansion
The sharp TTM revenue step-up indicates meaningful expansion in the company’s reported business scale. If retained across its branded food and pharmaceutical portfolio, this growth can broaden operating reach and provide a stronger base for future earnings generation.
Diversified Business Portfolio
Meiji combines branded consumer food operations with prescription pharmaceuticals and vaccines, giving the group exposure to multiple end markets. This portfolio breadth can reduce reliance on any single product category and supports a more durable business model over time.
Bears Say
Negative Free Cash Flow
Negative free cash flow and its sharp deterioration indicate that recent operations have not translated efficiently into cash available after investment. Persistent pressure of this kind could constrain internally funded growth, dividends, or other capital-allocation priorities.
Modest Profitability
A modest net margin leaves less room to absorb cost, mix, or execution pressure than a higher-margin business would have. The decline from earlier profitability peaks also suggests that recent revenue growth has not fully converted into stronger bottom-line earnings.
Weak Cash Conversion
Operating cash flow converting only a limited portion of reported net income points to weaker earnings quality in the latest period. Unless conversion improves, accounting profits may provide less support for reinvestment, deleveraging, and shareholder distributions.
Meiji Holdings Co News
MEJHF FAQ
What was Meiji Holdings Co’s price range in the past 12 months?
What is Meiji Holdings Co’s market cap?
When is Meiji Holdings Co’s upcoming earnings report date?
How were Meiji Holdings Co’s earnings last quarter?
Is Meiji Holdings Co overvalued?
Does Meiji Holdings Co pay dividends?
What is Meiji Holdings Co’s EPS estimate?
How many shares outstanding does Meiji Holdings Co have?
What happened to Meiji Holdings Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Meiji Holdings Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Meiji Holdings Co
Meiji Holdings Co., Ltd., established in Tokyo, Japan, in 1916, operates globally as a prominent manufacturer and seller across two core business segments: Food and Pharmaceutical. Its extensive Food division produces and markets a wide array of products, including various dairy items like yogurts, milk, cheeses, butter, and ice cream. This segment also encompasses a diverse selection of confectioneries, such as chocolates, gummy treats, and candies, alongside nutritional offerings like sports supplements, infant formulas, and beauty aids. Further contributions from the Food sector include frozen foods, sugar, over-the-counter medications, and livestock products, complemented by essential transportation and distribution services. The Pharmaceutical segment is dedicated to the development and provision of human health solutions, specifically targeting infectious diseases and central nervous system disorders, as well as manufacturing generic drugs, human and animal vaccines, and blood plasma products. Additionally, this division supplies a comprehensive range of veterinary medicines for livestock, fisheries, and companion animals, covering antimicrobials, pain relief, anti-inflammatory agents, and specialized treatments, alongside agricultural and livestock chemicals.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Katsunari Matsuda
- Employees
- 17,103
- Website
- www.meiji.com
- Address
- 2-4-16, Kyobashi, Tokyo, TY, 104-0031, JP
Meiji Holdings Co (MEJHF) Earnings & Revenues
MEJHF Company Deck
MEJHF Earnings Call
Earnings Call SentimentNeutral
The earnings call presented a mixed picture with strong performances in the Pharmaceutical segment and growth in certain brands, but faced challenges in the Food segment, particularly in China and the U.S. The decline in profits and the revised vaccine outlook were notable concerns.
View all MEJHF earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 3 | 4 |
| Technical Analysis | 4 | 3 | 1 |
| Moving Averages | 9 | 0 | 3 |







